Leider Harry L. 4
4 · Organicell Regenerative Medicine, Inc. · Filed Jun 30, 2023
Insider Transaction Report
Form 4
Leider Harry L.
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2023-06-29$0.01/sh+500,000$5,000→ 1,049,450 total(indirect: See footnote) - Purchase
Common Stock
2023-06-28$0.10/sh+549,450$54,396→ 549,450 total(indirect: See footnote)
Footnotes (1)
- [F1]The shares are held by the Harry L. Leider Revocable Trust of which the Reporting Person is the Trustee.